Back
Akebia Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62
AKBA
Akebia Therapeutics
Last Price:
$3.86
Seasonality Move:
-10.07%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and AKBA is experiencing selling pressure, which indicates risk of future bearish movement.
Akebia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.92 | Sell |
| 20-day SMA: | 3.76 | Buy |
| 50-day SMA: | 3.37 | Buy |
| 200-day SMA: | 2.27 | Buy |
| 8-day EMA: | 3.87 | Sell |
| 20-day EMA: | 3.76 | Buy |
| 50-day EMA: | 3.39 | Buy |
| 200-day EMA: | 2.46 | Buy |
Akebia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 60.69 | Buy |
| Chaikin Money Flow: | -1743367 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.57 - 3.87) | Buy |
| Bollinger Bands (100): | (1.91 - 3.49) | Buy |
Akebia Therapeutics Technical Analysis
| Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akebia Therapeutics Stock
Is Akebia Therapeutics Stock a Buy?
-
Akebia Therapeutics share price is 3.86 while AKBA 8-day simple moving average is 3.92, which is a Sell signal.
-
The stock price of AKBA is 3.86 while Akebia Therapeutics 20-day SMA is 3.76, which makes it a Buy.
-
Akebia Therapeutics 50-day simple moving average is 3.37 while AKBA share price is 3.86, making it a Buy technically.
-
AKBA stock price is 3.86 and Akebia Therapeutics 200-day simple moving average is 2.27, creating a Buy signal.
AKBA Technical Analysis vs Fundamental Analysis
Buy
62
Akebia Therapeutics (AKBA)
is a Buy
Is Akebia Therapeutics a Buy or a Sell?
-
Akebia Therapeutics stock is rated a BuyThe current Akebia Therapeutics [AKBA] share price is $3.86. The Score for AKBA is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Akebia Therapeutics Stock Info
Market Cap:
1B
Price in USD:
3.86
Share Volume:
3.1M
Akebia Therapeutics 52-Week Range
52-Week High:
4.08
52-Week Low:
1.07
Buy
62
Akebia Therapeutics (AKBA)
is a Buy
Akebia Therapeutics Share Price Forecast
-
What is the Akebia Therapeutics stock price today?The Akebia Therapeutics stock price is 3.86 USD today.
-
Will AKBA stock go up or go down?Akebia Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Akebia Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akebia Therapeutics is not overvalued.
Is Akebia Therapeutics Stock a Buy?
-
Akebia Therapeutics share price is 3.86 while AKBA 8-day exponential moving average is 3.87, which is a Sell signal.
-
The stock price of AKBA is 3.86 while Akebia Therapeutics 20-day EMA is 3.76, which makes it a Buy.
-
Akebia Therapeutics 50-day exponential moving average is 3.39 while AKBA share price is 3.86, making it a Buy technically.
-
AKBA stock price is 3.86 and Akebia Therapeutics 200-day simple moving average is 2.46, creating a Buy signal.
Fundamental Analysis of Akebia Therapeutics
Is Akebia Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.12 per share, an increase this year of $0.21 per share, and an increase next year of $0.32 per share.
Technical Analysis of Akebia Therapeutics
Should I short Akebia Therapeutics stock?
-
AKBA Moving Average Covergence Divergence (MACD) indicator is 0.15, suggesting Akebia Therapeutics is a Buy
-
Akebia Therapeutics Relative Strength Index (RSI) is 60.69, which suggest Akebia Therapeutics is overbought
-
The Bollinger Bands (25) for Akebia Therapeutics is (3.57 - 3.87), which suggest Akebia Therapeutics is a Buy
-
The Bollinger Bands (100) for Akebia Therapeutics is (1.91 - 3.49), which suggest Akebia Therapeutics is a Buy
* Akebia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.